Somatropin biosimilar (Anhui Anke Biotechnology)

生长激素类似物 (安徽安科生物工程(集团)股份有限公司)

Report date: 2022/01/14 16:23:50

Base Information

Drug NameSomatropin biosimilar (Anhui Anke Biotechnology)
Drug Alias Name生长激素生物类似物和生长激素生物仿制药rHGH (solution, growth disorder)安苏萌
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar
Mechanisms of ActionGrowth hormone receptor agonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsGrowth hormone deficiencyIdiopathic short statureBurns +[4] 
Global Approved IndicationsGrowth hormone deficiencyBurns
Approved Indications in ChinaGrowth hormone deficiencyBurns
Original Approved Country/TerritoryMainland China
Original Approved Date1999/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAnhui Anke Biotechnology (Group) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAnhui Anke Biotechnology (Group) Co Ltd
Inactive CompaniesN/A
Active IndicationsGrowth hormone deficiencyIdiopathic short statureBurns +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeH01AC01
Related LinksN/A